Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (451-460 of 498) with videos related to

Pageof 50
Sort By:
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
JNCI Cancer Spectrum|August 1, 2023
Use of the Decipher genomic classifier among men with prostate cancer in the United StatesNicholas G Zaorsky, James A Proudfoot, Angela Y Jia, et al.
The Lancet. Oncology|January 20, 2022
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Holly Hartman, et al.
Nature Communications|September 27, 2019
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programDavid P Labbé, Giorgia Zadra, Meng Yang, et al.
European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Pageof 50

Showing results (451-460 of 498) with videos related to

Sort By:
Pageof 50
NPJ Digital Medicine|June 8, 2022
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
NPJ Digital Medicine|February 22, 2023
Author Correction: Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trialsAndre Esteva, Jean Feng, Douwe van der Wal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 5, 2021
NCCN Guidelines Insights: Prostate Cancer, Version 1.2021Edward Schaeffer, Sandy Srinivas, Emmanuel S Antonarakis, et al.
JNCI Cancer Spectrum|August 1, 2023
Use of the Decipher genomic classifier among men with prostate cancer in the United StatesNicholas G Zaorsky, James A Proudfoot, Angela Y Jia, et al.
The Lancet. Oncology|January 20, 2022
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysisAmar U Kishan, Yilun Sun, Holly Hartman, et al.
Nature Communications|September 27, 2019
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC programDavid P Labbé, Giorgia Zadra, Meng Yang, et al.
European Urology|December 9, 2020
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate CancerNeil K Jairath, Alan Dal Pra, Randy Vince, et al.
JAMA Network Open|December 29, 2021
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysisTing Martin Ma, Tahmineh Romero, Nicholas G Nickols, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
The Lancet. Oncology|March 20, 2025
Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortiumAmar U Kishan, Yilun Sun, Alison C Tree, et al.
Pageof 50